Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1158/0008-5472.CAN-14-0266 http://scihub22266oqcxt.onion/10.1158/0008-5472.CAN-14-0266 C4112560!4112560!24713433     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cancer+Res 2014 ; 74 (11): 2922-7 Nephropedia Template TP {{tp|p=24713433|t=2014. Cancer Stem Cells: Constantly Evolving and Functionally Heterogeneous Therapeutic Targets |pdf=|usr=}}{{24713433}} gab.com Text Cancer Stem Cells: Constantly Evolving and Functionally Heterogeneous Therapeutic Targets JO: Cancer Res http://www.kidney.de/pget.php?&tw=1&pmid=24713433 #FOAvip Elucidating the origin of and dynamic interrelationship between intratumoral cell subpopulations has clear clinical significance in helping understand the cellular basis of treatment response, therapeutic resistance, and tumor relapse. Cancer stem cells (CSC), together with clonal evolution driven by genetic alterations, generate cancer cell heterogeneity commonly observed in clinical samples. The 2013 Shanghai International Symposium on Cancer Stem Cells# brought together leaders in the field to highlight the most recent progress in phenotyping, characterizing, and targeting CSC and in elucidating the relationship between the cell-of-origin of cancer versus CSC. Discussions from the symposium emphasize the urgent need in developing novel therapeutics to target the constantly evolving CSC. Twit Text FOAVip Cancer Stem Cells: Constantly Evolving and Functionally Heterogeneous Therapeutic Targets ????Cancer Res http://www.kidney.de/pget.php?&tw=1&pmid=24713433 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24713433 #FOAvip English Wikipedia <ref>{{Cite pmid|24713433}}</ref> Cancer Stem Cells: Constantly Evolving and Functionally Heterogeneous Therapeutic Targets #MMPMID24713433 Yang T; Rycaj K; Liu ZM; Tang DG Cancer Res 2014[Jun]; 74 (11): 2922-7 PMID24713433show ga Elucidating the origin of and dynamic interrelationship between intratumoral cell subpopulations has clear clinical significance in helping understand the cellular basis of treatment response, therapeutic resistance, and tumor relapse. Cancer stem cells (CSC), together with clonal evolution driven by genetic alterations, generate cancer cell heterogeneity commonly observed in clinical samples. The 2013 Shanghai International Symposium on Cancer Stem Cells# brought together leaders in the field to highlight the most recent progress in phenotyping, characterizing, and targeting CSC and in elucidating the relationship between the cell-of-origin of cancer versus CSC. Discussions from the symposium emphasize the urgent need in developing novel therapeutics to target the constantly evolving CSC. äCancer Stem Cells: Constantly Evolving and Functionally Heterogeneous (epmc).pdf DeepDyve Pubget Overpricing